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The sixty-seven papers in this book are grouped under the following
chapters: Esterase Structures, Catalytic Properties of Cholinesterases, Ca-
talytic Properties of Paraoxonases and Related Esterases, Biology of Cholin-
esterases, Biology of Paraoxonases and Related Esterases, Toxicity and Deg-
radation of Organophosphorus Compounds, Neuropathy Target Esterase,
and Miscellaneous. The chapters are preceded by a Preface and followed by
the Author and Subject Indexes.
The book represents investigations of cholinesterases, esterases hydro-
lyzing organophosphorus compounds (OP) and neuropathy target esterases,
carried out in the last six years, in succession of the results published in the
collection of papers presented at the Second International Meeting on Es-
terases in 1992 (Chemico-Biological Interactions, Vol 87, No. 1–3, 1993).
In order to hydrolyze acetylcholine in the extracellular space, cholines-
terases need to be exposed on the outside layer of the cell membrane or ex-
ported from cells. In vertebrates, these molecules are generated from a sin-
gle gene: the catalytic domain may be associated with a small C-terminal
region, encoded by several exons, and their alternative splicing defines the
types of catalytic subunits (AChES, AChEH, AChET) and determines their
post-translational maturation. AChES generates soluble monomers whereas
AChEH generates GPI-anchored dimers in Torpedo muscles and on mam-
malian blood cells. In all vertebrate cholinesterases, AChET is the only type
of catalytic subunit, appearing as monomer, dimer or collagen-tailed and
hydrophobic-tailed tetramer. In the collagen-tailed forms, AChET subunits
are associated with a specific collagen, Col Q, which through its hydrophobic
tail anchors AChE in mammalian brain membranes.
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The three-dimensional structure of AChE from Torpedo californica, to-
gether with kinetic, spectroscopic and side-directed mutagenesis studies,
has permitted identification of the amino acid residues that interact with
the natural substrate. The structure revealed that the active side is located
near the bottom of a deep and narrow gorge lined with 14 conserved aro-
matic amino acids. It was found that the AChE active site possesses an oxy-
anion hole, an acyl binding pocket, and a choline binding site. The aromatic
side chains constituting the acyl pocket and the residues in the oxyanion
hole participate in acylation and deacylation of AChE. The intermediate
complex is accommodated at the bottom of the gorge.
There are two sites of ligand interaction in AChE: an acylation site at
the base of the gorge, and a peripheral site at its mouth. Ligands can bind
selectively to either the acylation or the peripheral sites. It was found that
peripheral site inhibitors affect the rate of phosphorylation of AChE with
organophosphates. A series of chiral methylphosphonates was studied, in
which the leaving group and the retained alkoxy group were systematically
modified in order to analyze inactivation and oxime reactivation of wild-
type and mutant cholinesterases. The efficacy of oxime reactivation is de-
pendent on both oxime and phosphonate structures.
Besides AChE, mammalian organisms also possess butyrylcholinester-
ase (BChE), another acethylcholine-hydrolyzing enzyme. Administration of
butyrylcholinesterase has been proposed as a treatment for organophos-
phate poisoning in mice, rats and non-human primates. This protective ef-
fect results from the covalent binding of BChE to organophosphates (OP),
thus precluding OP binding to and inactivation of AChE at nerve synapses
of the central and peripheral nervous system. Human BChE is composed
predominantly of tetramers. The tetramerization domain of BChE is at the
carboxy-terminus. Stabilization of the tetramer is mediated through the in-
teraction of seven conserved aromatic residues and the proline-rich attach-
ment domain of collagen. Differences in active-site gorge dimensions of cho-
linesterases were revealed by binding inhibitors to human BChE. It was
found that the volume of the BChE active-site gorge is  A3 larger than that
of the AChE gorge. The results obtained suggest that the dimensions and
the micro-environment of the gorge play a significant role in determining
the selectivity of the substrate and inhibitors for cholinesterases.
Human serum paraoxonase/arylesterase (PON) is a calcium-dependent
enzyme that hydrolyzes a wide variety of organophosphates, including para-
oxone, diisopropyl-fluoro-phosphate, sarin and soman. By group selective la-
belling and site-directed mutagenesis, the essential amino acid residues
were identified in the enzyme. In human populations, serum paraoxonase
exhibits a substrate dependent polymorphism. It was shown that PON plays
a major role in the detoxication of organophosphates processed through the
P450/PON1 pathway. PON is a key component of the HDL complex, and
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PON is able to inactivate toxic products resulting from the oxidation of lipid
components of the blood LDL. Mature PON retains its N-terminal hydro-
phobic signal sequence that may be needed for binding to the Apo A-1 pro-
tein of HDL. Thus, the anti-atherogenic qualities of HDL may derive in part
from its content of PON. Protection of endothelial and other cells against
oxidative damage due to oxidized LDL lipoproteins, and the in vivo protec-
tion by PON against endotoxic damage by bacterial lipopolysaccharides sug-
gest that PON has a stabilizing property for cellular membranes that un-
dergo either acute or chronic exposure to oxidative agents and free radicals.
Organophosphorus compounds are a broad class of neurotoxic chemicals,
which may be used as pesticides or chemical warfare agents. The toxicity of
OP compounds is dramatically reduced by chemical or enzymatic hydrolysis.
Enzymes hydrolyzing OP compounds, like human paraoxonase, organophos-
phorus hydrolase (OPH) and organophosphorus anhydrolase (OPAA), accom-
plish this hydrolysis by cleaving P–C, P–O, P–F, P–S and P–CN bonds in
specific OP compounds. Recently, and for the first time, an OPAA has been
reported in a plant source: in duckweed, germinated mung bean and in a
slime mold (Dictyostelium discoideum).
The interest in OPH and OPAA enzymes received a boost with the puri-
fication of the enzymes from Pseudomonas diminuta MG and Flavobacte-
rium ATCC 27551. The gene (opd) encoding OPH was found to be associated
with the large plasmid of dissimilar size in P. diminuta and F. sp. The DNA
sequences for opd genes have been determined and the gene has been ex-
pressed in a variety of vectors using host-specific promoters. Recently, the
genes encoding OPAA from two species of Alteromonas were cloned and se-
quenced. Efforts to overproduce an OPAA from A. sp. ID 6.5 with the goal of
developing strategies for long term storage and decontamination have been
successful. Inclusion of OPAA enzyme into spray or foam provides a basis
for the development of an enzyme-based decontaminant system.
In order to protect OP-contaminated persons, a sponge product com-
posed of a ChE, oxime, and polyurethane foam was prepared for the removal
and decontamination of OP compounds from biological surfaces such as
skin. These polyurethane ChE-sponges exhibit remarkable long-term stabil-
ity and increased resistance to elevated temperature.
It was established long ago that OP-esters exert their primary toxic ef-
fect on cholinergic synapses. The main disadvantage of the use of OP com-
pounds as pesticides is the associated toxicity. The toxic effect of certain OP
compounds, quite distinct from the inhibition of AChE, is their ability to
cause progressive degeneration of long axons, leading to ataxia. Degenera-
tion can occur over a period of several weeks after a single insult with a
neuropathic OP compound. This delayed neuropathy is mediated through
reaction of the OP compound with neuropathy target esterase (NTE). The
mechanism of OP-induced delayed polyneuropathy and the function of NTE
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are still unknown. Simple inhibition of NTE esterase activity does not initi-
ate neuropathy; the latter requires aging of the OP bound to the catalytic
serine residue. This may indicate that a non-esterase function of NTE is im-
portant for axonal maintenance. Recently, NTE was cloned and it was found
that it contains a novel C-terminal domain which is conserved from bacteria
to man. The catalytic serine is located within this domain. NTE is defined
as phenyl valerate esterase, resistant to non-neuropathic paraoxon and sus-
ceptible to neuropathic mipafox.
Only one paper concerning the nomenclature system for the paraoxonases
was published. A consensus was reached as to a preferred system for num-
bering the paraoxonase amino acid residues that could be recommended for
general use by all workers in this field.
In conclusion, this book represents a balanced and comprehensive ac-
count of the achievements in the last six years. Scientists from all promi-
nent laboratories in this field have contributed to this book. Out of the pub-
lished papers, I have described those which represent a particular challenge
to further investigations. Readers who have access to previous volumes will
be able to follow the history of the field and the ebb and tide of » hot topics«
at each Meeting, while those who pick up this new volume might welcome
some papers appearing in each chapter. This book will be of interest to bio-
chemists, toxicologists and pharmacologists.
Pavao Mildner
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